{"uuid": "29ce46d5-a0a6-8f93-a4ba-4e991f4b14c0", "code": "mv-2018-autumn-fulltime-c5", "state": {"code": "confirmed", "et": "Kinnitatud", "en": "confirmed"}, "last_update": "2024-08-29T13:38:01", "title": {"en": "Pharmacotherapy", "et": "Farmakoteraapia"}, "credits": 5, "credit_type": "ECTS", "target": {"year": {"code": "2018", "et": "2018/2019", "en": "2018/2019"}, "semester": {"code": "autumn", "et": "sügis", "en": "autumn"}, "study_type": {"code": "fulltime", "et": "päevaõpe", "en": "regular studies"}, "language": {"code": "et", "et": "eesti keel", "en": "Estonian"}, "part": {"code": "0", "et": "Osadeta", "en": "None"}, "faculty": {"code": "MV", "name": {"en": "Faculty of Medicine", "et": "meditsiiniteaduste valdkond"}, "address": "Tartu linn, \nTartu linn, Tartumaa \nEST", "city": "Tartu linn", "level": 1, "academic": true, "supports_continuous_learning": true}, "course_main_structural_unit": {"code": "MVBS02", "name": {"en": "Department of Pharmacology", "et": "farmakoloogia osakond"}, "phone": "+372 737 4350", "webpage_url": "https://biomeditsiin.ut.ee/et/sisu/farmakoloogia-osakond", "address": "EST", "level": 3, "academic": true, "supports_continuous_learning": false, "parent_code": "MVBS"}, "label": {"en": "18/19 A regular MV", "et": "18/19 S PÕ MV"}}, "general": {"year": {"code": "2018", "et": "2018/2019", "en": "2018/2019"}, "input_languages": [{"code": "et", "et": "eesti keel", "en": "Estonian"}], "structural_unit_shares": [{"structural_unit_code": "MVBS02", "structural_unit_name": {"en": "Department of Pharmacology", "et": "farmakoloogia osakond"}, "course_share_percent": 100, "coordinating": true}], "type": {"code": "regular", "et": "Tavaline aine", "en": "Regular course"}}, "additional_info": {"is_vota_course": true, "is_continuous_learning_course": false, "study_levels": [{"code": "bachelor_master", "et": "integreeritud bakalaureuse- ja magistriõpe", "en": "integrated bachelor's and master's studies"}], "hours": {"lecture": 32, "practice": 0, "seminar": 33, "colloquium": 0, "web_learning": 0, "independent_work": 65, "individual_work": 0, "internship": 0}, "prerequisites": [{"required": true, "uuid": "c6193e61-ba7a-08ea-a283-98211618f47b", "code": "ARFR.02.051", "title": {"en": "Pharmacology", "et": "Farmakoloogia"}, "credits": 11, "state": {"code": "confirmed", "et": "Kinnitatud", "en": "confirmed"}, "last_update": "2024-02-05T11:04:36"}], "is_enlight_course": false}, "overview": {"study_languages": [{"code": "et", "et": "eesti keel", "en": "Estonian"}], "description": {"en": "Teaching is provided as lectures and seminars. Teaching focuses on the following problems: farmacotherapy of skin diseases, migraines, skeletal and muscular system, anxiety and depression, osteoporosis,  respiratory tract diseases, cardiovaslular diseases, infectious diseases and using of food supplements.", "et": "Õppetöö toimub loengute ja seminaride näol. Õppetöö on keskendunud järgmistele probleemidele: nahahaiguste, migreeni, skeleti- ja lihassüsteemi haiguste, osteoporoosi, ärevuse ja depressiooni, hingamisteede haiguste, kardiovaskulaarsüsteemi haiguste, seedetrakti haiguste  ja infektsioonihaiguste farmakoteraapia ning toidulisandite kasutamise tõenduspõhisus."}, "objectives": [{"en": "The primary aim of the course is to link the basic pharmacological knowledge with the therapeutic concepts of the science-based medicine to provide a cknowledge how optimize treatment option for a particular patient.", "et": "Kursuse esmaseks eesmärgiks on siduda baasfarmakoloogiaalased teadmised terapeutilise kontseptsiooniga, mis baseerub tõenduspõhisel meditsiinil ja konkreetse patsiendi raviks optimaalse ravimi valikul. Kursuse käigus saavad üliõpilased ülevaate enamlevinud haigustest ja raviskeemidest ning käsitletakse patsientide nõustamise võimalusi apteegis."}], "learning_outcomes": [{"en": "1. Student is able to evaluate make pharmacotherapeutic drug selection for the treament of the most important diseases.", "et": "1. Üliõpilane oskab kritiiliselt hinnata ravimi valikut tähtsamate haiguste ravis."}, {"en": "2. Students is able to describe the potential hazard of drug use in children, aged patients,  durinfg pregnancy, or in patients with kidney, liver, heart diseases.", "et": "2. Üliõpilane tunneb ravimeid, mis on potentsiaalselt ohtlikud kasutamiseks, lastel, eakatel, raseduse ajal, või neeru-, maksa- või südamehaigetel."}, {"en": "3. Students know side effects and drug interactions for the most important drugs.", "et": "3. Üliõpilane teab tähtsamate ravimite kõrval- ja koostoimeid. "}, {"en": "4. Studens knows how conflict of interewsts might affect rational drug choice for treatment of diseases.", "et": "4. Üliõpilane saab aru, kuidas huvide konfiktid võivad mõjutada ratsionaalset ja objektiivset ravimite kasutamist."}], "notes": {}}, "grading": {"independent_work": {}, "independent_work_assessments": [{"work_type": {"code": "written", "et": "Kirjalik lõpphindamine", "en": "final written assessment"}, "description": {"et": "Hindamismeetodiks on kirjalik eksam. Eksam koosneb 50 valikvastustega küsimustest ja ülesannetest. Iga õige vastuse eest saab (sõltuvalt küsimuse tüübist) 1-3 punkti. Hindamine on eristav ja lävend on 70% (F * 69 punkti)."}}], "grade_preconditions": {"et": "Eksamile pääsemiseks peab üliõpilane olema osa võtnud vähemalt 15 loengust ja seminarist. Rohkem kui ühe seminarist puudumise eest tuleb kirjutada referaat. Referaadi teema annab seminari läbiviinud õppejõud."}, "grade_evaluation": {"et": "Hindamismeetodiks on kirjalik eksam. Eksam koosneb 50 valikvastustega küsimustest ja ülesannetest. Iga õige vastuse eest saab (sõltuvalt küsimuse tüübist) 1-3 punkti. Hindamine on eristav ja lävend on 70% (F * 69 punkti)."}, "debt_elimination": {"et": "Võlgnevuste likvideerimine toimub jooksvalt."}, "assessment_scale": {"code": "grade", "et": "Eristav (A, B, C, D, E, F, mi)", "en": "differentiated (A, B, C, D, E, F, not present)"}, "results_available_from": {}}, "resources": {"web_based": {"code": "2", "et": "põimõpe", "en": "blended learning"}, "website_url": "http://moodle.ut.ee", "is_moodle_connected": false, "mandatory_materials": "1. Katzung B.C. Basic and Clinical Pharmacology: Appleton & Lange, 2007\n2. Laurence D. R., Bennett P. N., Brown M. J. Clinical Pharmacology, Churchill\n3. British National Formulary, www.bnf.org", "recommended_materials": "1. P. Kumar, M. Clark. Clinical Medicine 6th ed., Bailliere Tindall, 2005.\n2. The Merck Manual, www.merckmanuals.com/professional/\n3. Ravimiinfo Bülletäänid, 1995-2009, www.ravimiamet.ee\n4. Randall MD, Neil KE. Disease Management. Pharmaceutical Press, 2003.\n5. Stillmann P, Edwards C. Minor Illness or Major Disease?: The Clinical Pharmacist in the Community. Pharmaceutical Press; 4th ed, 2006.\n6. Ajakirjad LegeArtis ja Eesti Arst"}, "participants": {"lecturers": [{"person_uuid": "41d1b716-8cd2-4c04-412d-e8c4c84e5ffb", "person_name": "Jana Lass", "structural_unit": {"code": "MVBS09MV", "name": {"en": "Chair of Medical Microbiology and Virology", "et": "meditsiinilise mikrobioloogia ja viroloogia õppetool"}, "phone": "+372 737 4170", "address": "EST", "level": 4, "academic": false, "supports_continuous_learning": false, "parent_code": "MVBS09"}, "is_responsible": false, "is_teaching": true, "study_group_roles": {"2. rühm": {"code": "1", "et": "Lektor", "en": "lecturer"}, "1. rühm": {"code": "1", "et": "Lektor", "en": "lecturer"}}}, {"person_uuid": "5def89b5-b907-74bc-c88e-7788bccb3303", "person_name": "Anti Kalda", "structural_unit": {"code": "MVBS02KF", "name": {"en": "Chair of Clinical Pharmacology", "et": "kliinilise farmakoloogia õppetool"}, "address": "EST", "level": 4, "academic": false, "supports_continuous_learning": false, "parent_code": "MVBS02"}, "is_responsible": true, "is_teaching": true, "study_group_roles": {"2. rühm": {"code": "1", "et": "Lektor", "en": "lecturer"}, "1. rühm": {"code": "1", "et": "Lektor", "en": "lecturer"}}}, {"person_uuid": "8aafb6f8-f10f-86cc-5268-116c844e7c9f", "person_name": "Aleksandr Žarkovski", "structural_unit": {"code": "MVBS02FT", "name": {"en": "Chair of Pharmacology and Toxicology", "et": "farmakoloogia ja toksikoloogia õppetool"}, "address": "EST", "level": 4, "academic": false, "supports_continuous_learning": false, "parent_code": "MVBS02"}, "is_responsible": false, "is_teaching": true, "study_group_roles": {"2. rühm": {"code": "1", "et": "Lektor", "en": "lecturer"}, "1. rühm": {"code": "1", "et": "Lektor", "en": "lecturer"}}}, {"person_uuid": "dea7ee31-da7f-6488-aae2-1a02575c326d", "person_name": "Džamilja Safiulina", "structural_unit": {"code": "MVBS02FT", "name": {"en": "Chair of Pharmacology and Toxicology", "et": "farmakoloogia ja toksikoloogia õppetool"}, "address": "EST", "level": 4, "academic": false, "supports_continuous_learning": false, "parent_code": "MVBS02"}, "is_responsible": false, "is_teaching": true, "study_group_roles": {"2. rühm": {"code": "1", "et": "Lektor", "en": "lecturer"}, "1. rühm": {"code": "1", "et": "Lektor", "en": "lecturer"}}}, {"person_uuid": "669285bf-6e50-bea8-a723-ea3c68a21626", "person_name": "Annika Vaarmann", "structural_unit": {"code": "MVBS02FT", "name": {"en": "Chair of Pharmacology and Toxicology", "et": "farmakoloogia ja toksikoloogia õppetool"}, "address": "EST", "level": 4, "academic": false, "supports_continuous_learning": false, "parent_code": "MVBS02"}, "is_responsible": false, "is_teaching": true, "study_group_roles": {"2. rühm": {"code": "1", "et": "Lektor", "en": "lecturer"}, "1. rühm": {"code": "1", "et": "Lektor", "en": "lecturer"}}}, {"person_uuid": "a9d60a0e-e357-583a-b54b-c62571406faf", "person_name": "Katrin Pruus", "structural_unit": {"code": "MVBS02FT", "name": {"en": "Chair of Pharmacology and Toxicology", "et": "farmakoloogia ja toksikoloogia õppetool"}, "address": "EST", "level": 4, "academic": false, "supports_continuous_learning": false, "parent_code": "MVBS02"}, "is_responsible": false, "is_teaching": true, "study_group_roles": {"2. rühm": {"code": "1", "et": "Lektor", "en": "lecturer"}, "1. rühm": {"code": "1", "et": "Lektor", "en": "lecturer"}}}, {"person_uuid": "783e3c04-4879-5cad-84b4-e50b1aaef9b8", "person_name": "Malle Kuum", "structural_unit": {"code": "MVBS02FT", "name": {"en": "Chair of Pharmacology and Toxicology", "et": "farmakoloogia ja toksikoloogia õppetool"}, "address": "EST", "level": 4, "academic": false, "supports_continuous_learning": false, "parent_code": "MVBS02"}, "is_responsible": false, "is_teaching": true, "study_group_roles": {"2. rühm": {"code": "1", "et": "Lektor", "en": "lecturer"}, "1. rühm": {"code": "1", "et": "Lektor", "en": "lecturer"}}}], "study_groups": [{"uuid": "a618063f-f24d-d6f3-be96-839cc37b8925", "code": "1. rühm"}, {"uuid": "43bd9906-87ff-8320-6734-7dc3fdf6ff08", "code": "2. rühm"}]}, "schedule": {"weeks": {"et": "1.-16. n., 2L n-s, 2S n-s, 1 tund võlgnevuste likvideerimiseks, E"}, "entries": [{"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Sissejuhatus farmakoteraapia kursusesse. Silmahaiguste farmakoteraapia"}}, {"work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Sissejuhatus farmakoteraapia kursusesse. Silmahaiguste farmakoteraapia"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Antibakteriaalne farmakoteraapia"}}, {"work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Antibakteriaalne farmakoteraapia"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Südame isheemiatõve ja düslipideemia farmakoteraapia"}}, {"work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Südame isheemiatõve ja düslipideemia farmakoteraapia"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Hüpertooniatõve ja südamepuudulikkuse farmakoteraapia"}}, {"work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Hüpertooniatõve ja südamepuudulikkuse farmakoteraapia"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Valu farmakoteraapia"}}, {"work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Valu farmakoteraapia"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "II tüüpi diabeedi farmakoteraapia"}}, {"work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "II tüüpi diabeedi farmakoteraapia"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Ärevusevastased ravimid ja depressiooni ravi"}}, {"work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Ärevusevastased ravimid ja depressiooni ravi"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Osteporoosi farmakoteraapia"}}, {"work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Osteporoosi farmakoteraapia"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Epilepsia ja migreeni farmakoteraapia"}}, {"work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Epilepsia ja migreeni farmakoteraapia"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Nohu ja köha farmakoteraapia"}}, {"work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Nohu ja köha farmakoteraapia"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Gripi, sinusiidi, otiidi ja tonsilliidi farmakoteraapia"}}, {"work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Gripi, sinusiidi, otiidi ja tonsilliidi farmakoteraapia"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Bronhiaalastma, bronhiit, krooniline obstruktiivne kopsuhaigus"}}, {"work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Bronhiaalastma, bronhiit, krooniline obstruktiivne kopsuhaigus"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Kontratseptsioon, hormoonasendusravi ja antiandrogeenid"}}, {"work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Kontratseptsioon, hormoonasendusravi ja antiandrogeenid"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Ravimite kasutamine gastroösofageaal-refluksi ja haavandtõve puhul"}}, {"work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Ravimite kasutamine gastroösofageaal-refluksi ja haavandtõve puhul"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Ravimite kasutamine kõhulahtisuse ja kõhukinnisuse puhul"}}, {"work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Ravimite kasutamine kõhulahtisuse ja kõhukinnisuse puhul"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Toidulisandid ja tõenduspõhine farmakoteraapia"}}, {"work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Toidulisandid ja tõenduspõhine farmakoteraapia"}}]}, "registration_info": {"audience": {"et": "Proviisoriõpe IV"}, "min_students": 5}, "parent_uuid": "ae7cda82-274d-9e3b-f696-01c1fd51b9b7", "parent_code": "ARFR.02.052", "parent_credits": 5, "_actions": {"is_editable": false, "is_moodle_editable": false, "is_deletable": false}}